Testing a three-ingredient asthma inhaler for people whose asthma isn't controlled

This trial is testing CHF 5993, a new asthma inhaler that combines three medicines in one device, to see if it works better than the current two-ingredient inhaler you may already be using. You would use either the new three-ingredient inhaler or continue with a two-ingredient inhaler for 24 weeks, and researchers would track how well your asthma is controlled. The study will help doctors understand whether adding a third medication can improve breathing and reduce asthma symptoms.

Many people with asthma still struggle to control their symptoms even when using two-ingredient inhalers at standard doses. This medication aims to give better control by adding a third ingredient, potentially helping patients breathe easier and avoid asthma attacks.